Morgan is on a limited schedule from July 1st — Sept 1st for Maternity Leave. Email us at info@morgandavislegal.com and someone from our team will be in touch.
September 30, 2024

DEA vs. Synthetic Cannabinoids: Key Takeaways from the Fourth Circuit Ruling


The hemp industry is buzzing over a recent ruling from the Fourth Circuit Court of Appeals in Anderson v. Diamondback, which challenges the DEA’s stance on synthetic cannabinoids. Here’s what you need to know about this pivotal case and its implications for hemp businesses.


Background: Anderson v. Diamondback

In this case, an employee was terminated after testing positive for THC. Key details include:

  • The Claim: Anderson argued her termination was unjust because her use of hemp products was lawful under North Carolina law.
  • The Ruling: The court ultimately sided with Diamondback, finding the termination lawful.
  • Significance: While Anderson’s claim was unsuccessful, the court’s analysis shed light on federal hemp laws and the definition of synthetic cannabinoids.

What the Fourth Circuit Said About Hemp and THC

The Fourth Circuit’s ruling clarified several critical points:

  1. Delta-9 THC as the Sole Marker:
  • The 2018 Farm Bill explicitly states that hemp is defined by a Delta-9 THC concentration of 0.3% or less by dry weight.
  • Other cannabinoids, including Delta-8, HHC, and THCO, are not inherently illegal under federal law if the Delta-9 THC limit is met.
  1. Rejection of DEA Authority:
  • The court emphasized that the DEA is not the best authority on hemp-related matters.
  • Instead, they cited the National Institute for Drug Abuse (NIDA) for a more scientific perspective on synthetic and naturally derived cannabinoids.
  1. Synthetic vs. Naturally Derived:
  • Synthetic cannabinoids are traditionally understood as man-made in a lab, mimicking cannabis but with vastly different effects.
  • Cannabinoids derived from hemp through processes like CBD conversion (e.g., Delta-8, HHC) are not considered fully synthetic. These are derived from plant material and retain effects similar to natural cannabis.

Implications for Hemp Businesses

This ruling has several major takeaways for hemp businesses:

Federal Clarity

  • Under federal law, products meeting the Delta-9 THC standard (0.3% or less) are considered hemp and are legal. This includes products containing Delta-8, HHC, and other cannabinoids, provided they meet this threshold.

State Laws Still Apply

  • Many states have implemented stricter regulations, including:
  • Total THC standards.
  • Milligram caps.
  • Bans on “synthetic” cannabinoids.
  • These laws remain enforceable until challenged or overturned.

DEA’s Role Diminished

  • The court’s rejection of the DEA’s interpretations provides businesses with a stronger argument against enforcement actions based on the DEA’s shifting positions.

Understanding Synthetic Cannabinoids

The term “synthetic” is a major point of contention in the hemp industry:

  • Traditional Definition: Fully lab-made compounds that mimic cannabis but often cause drastically different effects.
  • Hemp-Derived Cannabinoids: Compounds like Delta-8 and HHC are typically created through CBD conversion and maintain effects similar to natural THC, distinguishing them from traditional synthetics.

The Fourth Circuit’s ruling aligns with the understanding that these products, derived from plant material, are not “synthetic” in the traditional sense.


What This Means for Your Business

For hemp producers and retailers:

  1. Federal Compliance:
  • Focus on ensuring Delta-9 THC concentrations remain within the legal limit.
  • Use this ruling as a defense against federal challenges.
  1. State-Specific Strategy:
  • Stay up-to-date on local regulations, which may impose stricter standards than federal law.
  • Advocate for clarity and fairness in state legislatures using this ruling as a precedent.
  1. Consumer Transparency:
  • Clearly label products with accurate THC concentrations and sourcing information.
  • Avoid misbranding to reduce the risk of enforcement actions.

Conclusion

The Fourth Circuit’s decision is a significant victory for the hemp industry, providing much-needed clarity on the legal status of hemp-derived cannabinoids. While this ruling bolsters the argument for federal legality, businesses must remain cautious and ensure compliance with both federal and state laws.

If you need assistance navigating these complex regulations or ensuring your products meet compliance standards, give us a call. We’re here to help protect your business and keep it thriving.

Related Articles

Schedule Your Consultation

Davis Legal, PLLC is here to listen, and we want to hear your whole story. When we clearly understand your goals and challenges, we can help you get where you want to go. Fill out the form and we'll contact you to schedule a free initial consultation.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This website uses cookies to ensure you get the best experience. Privacy Policy